Kirsten Bornemann-Kolatzki

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Glen J. Weiss, Lisa Blaydorn, Julia Beck et al. · Investigational New Drugs · 2017 · 210 citations

Pancreatic Cancer, Gastrointestinal Oncology, Metastatic Pancreatic Adenocarcinoma +8

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

Eva Schrezenmeier, Héctor Rincón-Arévalo, Annika Jens et al. · JCI Insight · 2022 · 90 citations · Full text

Transplant Recipients, Immunology, Immunotherapy +21

Molecular Classification of Neuroendocrine Tumors of the Thymus

Helen Dinter, Hanibal Bohnenberger, Julia Beck et al. · Journal of Thoracic Oncology · 2019 · 67 citations · Full text

Genome Aberrations in Canine Mammary Carcinomas and Their Detection in Cell-Free Plasma DNA

Julia Beck, Silvia Hennecke, Kirsten Bornemann-Kolatzki et al. · PLoS ONE · 2013 · 65 citations · Full text

Canine Mammary Carcinomas, Cancer Pathology, Mammary Tumors +16

Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer

Ekkehard Schütz, Mohammad R. Akbari, Julia Beck et al. · Clinical Chemistry · 2014 · 47 citations · Full text